Truveris Expands Audit Capabilities with Launch of TruAudit™
Jun 12, 2018 10:23:56 AM |
Press Releases
Truveris announced new audit capabilities geared towards further increasing transparency in the pharmacy benefit space.
Truveris Appoints Sally Welborn, former head of Walmart Global Benefits to Board of Directors
Mar 20, 2018 10:36:44 AM |
Press Releases
Truveris announced that Sally Welborn, the former senior vice president of global benefits at Walmart, was elected to the Truveris board of directors.
Truveris Ranked 205th Fastest Growing Company in North America on Deloitte’s 2017 Technology Fast 500™
Nov 9, 2017 4:23:46 PM |
Press Releases
Truveris today announced it ranked 205th on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy-tech companies in North America. Truveris grew 499% percent during this period.
Truveris Secures $25 Million in New Funding to Help Reduce Cost and Improve Access to Prescription Medications
Sep 6, 2017 9:00:00 AM |
Press Releases
McKesson Ventures led the funding round with existing investors to advance the company’s data and insights capabilities, which help manage rising prescription drug costs.
State of New Jersey Cutting Prescription Drug Spend by 18% with Truveris TruBid® & Bill Review Technology
Aug 7, 2017 12:09:34 PM |
Press Releases
The outcome of a contract between Truveris and the State of New Jersey to assist with reducing the State’s prescription drug spend will result in a savings of approximately 18%.
Prescription Drug Prices Continue to Climb, Soaring 8.77% in Latest Truveris NDI Report
May 10, 2017 1:58:00 PM |
Press Releases
Prescription drug prices soared 8.77% in 2016, representing the fourth consecutive year of inflation above 8%.
Truveris Strengthens Leadership Team with Appointment of Faisal Mushtaq as Chief Executive Officer
Sep 22, 2016 1:56:00 PM |
Press Releases
Truveris, a leading provider of solutions across the prescription drug ecosystem, announced the appointment of Faisal Mushtaq as the chief executive officer.
Consumers Increasingly Walk Away from Prescription Drugs When Prices Reach $50, Creating Trend Toward Medication Abandonment, According to Truveris Data
Mar 22, 2016 1:55:00 PM |
Press Releases
Consumers increasingly walk away from prescription drugs that treat medical conditions when prices reach the $50 threshold.
New App Helps Consumers Find More Ways to Save on Prescription Drugs
Aug 5, 2015 1:46:00 PM |
Press Releases
OneRx enables consumers to review drug pricing and benefits data, offering the most robust prescription drug savings tool in the marketplace.
2015 Prescription Drug Prices Jump Another 3.8% in Q1, According to Truveris National Drug Index
Apr 28, 2015 1:44:00 PM |
Press Releases
Truveris continues to spotlight prescription drug cost increases with 2015 data from the Truveris National Drug Index (NDI).
Truveris Launches Pharmacy Stop Loss Insurance Platform to Protect Employers from Rising Benefits Costs
Mar 17, 2015 12:00:00 AM |
Press Releases
Truveris has introduced a new product to enable benefits brokers and advisors help companies more easily take advantage of stop loss insurance.
Americans Faced Double Digit Increases in Prescription Drug Prices in 2014, According to Truveris National Drug Index
Jan 26, 2015 12:00:00 AM |
Press Releases
Americans faced double-digit price increases for prescription medications in 2014, according to the Truveris National Drug Index.
Truveris Debuts NDI National Drug Index
Nov 19, 2014 12:00:00 AM |
Press Releases
Truveris Debuts NDI National Drug Index
Truveris Launches RxChoice, the Industry’s First Pharmacy Benefit Marketplace
Sep 23, 2014 12:00:00 AM |
Press Releases
Truveris Launches RxChoice
Truveris launches RxDash, a Game-Changer that Allows Instant Price and Plan Design Modeling for Pharmacy Benefits Changes
Aug 20, 2014 12:00:00 AM |
Press Releases
Truveris Launches RxDash
Pharmacy Pricing & Benefits Analysis Platform Truveris Raised Another $12.75M
Jun 27, 2014 12:00:00 AM |
Press Releases
Truveris raises $12.8M in Series C